Lanreotide
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
108736-35-2
Chemical name
Lanreotide
Molecular formula
C54H69N11O10S2
Molecular weight
1096.3 g/mol
Synonyms
Ipstyl; Lanreotida; Lanreotidum; Lanreotide Autogel; BIM 23014; DC 13-116; Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2; Somatulina; Somatuline LA; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide; BIM 23014C; Dermopeptin
InChIKey
PUDHBTGHUJUUFI-SCTWWAJVSA-N
PubChem CID
6918011
No GHS reference data is available in the current MolGraph catalog record.
Appearance
White to off-white powder or crystals
Catalog reference value; verify against supplier SDS before use.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.